Relief Therapeutics and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress

gparkof1 In the News

 

Now developing RLF-100 for treatment of COVID-19-related
Acute Respiratory Distress (ARDS)
in partnership with Relief Therapeutics

Learn more about RLF-100 HERE